Живи долго! Научный подход к долгой молодости и здоровью. Майкл Грегер
Am J Clin Nutr. 2000;72(4):998–1003. https://pubmed.ncbi.nlm.nih.gov/11010943/
662
Mathers JC, Strathdee G, Relton CL. Induction of epigenetic alterations by dietary and other environmental factors. Adv Genet. 2010;71:3–39. https://pubmed.ncbi.nlm.nih.gov/20933124/
663
Eaton SB, Eaton SB. Paleolithic vs. modern diets – selected pathophysiological implications. Eur J Nutr. 2000;39(2):67–70. https://pubmed.ncbi.nlm.nih.gov/10918987/
664
Метилентетрагидрофолатредуктаза, ключевой фермент фолатного цикла. –
665
Parkhurst E, Calonico E, Noh G. Medical decision support to reduce unwarranted methylene tetrahydrofolate reductase (MTHFR) genetic testing. J Med Syst. 2020;44(9):152. https://pubmed.ncbi.nlm.nih.gov/32737598/
666
Levin BL, Varga E. MTHFR: addressing genetic counseling dilemmas using evidence-based literature. J Genet Couns. 2016;25(5):901–11. https://pubmed.ncbi.nlm.nih.gov/27130656/
667
Porter K, Hoey L, Hughes CF, Ward M, McNulty H. Causes, consequences and public health implications of low B-vitamin status in ageing. Nutrients. 2016;8(11). https://pubmed.ncbi.nlm.nih.gov/27854316/
668
Friso S, Choi SW, Girelli D, et al. A common mutation in the 5,10-methylenetetrahydrofolate reductase gene affects genomic DNA methylation through an interaction with folate status. Proc Natl Acad Sci USA. 2002;99(8):5606–11. https://pubmed.ncbi.nlm.nih.gov/11929966/
669
Bailey LB. Folate, methyl-related nutrients, alcohol, and the MTHFR 677C®T polymorphism affect cancer risk: intake recommendations. J Nutr. 2003;133(11 Suppl 1):3748S-53S. https://pubmed.ncbi.nlm.nih.gov/14608109/
670
Levin BL, Varga E. MTHFR: addressing genetic counseling dilemmas using evidence-based literature. J Genet Couns. 2016;25(5):901–11. https://pubmed.ncbi.nlm.nih.gov/27130656/
671
Parkhurst E, Calonico E, Noh G. Medical decision support to reduce unwarranted methylene tetrahydrofolate reductase (MTHFR) genetic testing. J Med Syst. 2020;44(9):152. https://pubmed.ncbi.nlm.nih.gov/32737598/
672
Seitz HK, Matsuzaki S, Yokoyama A, Homann N, Väkeväinen S, Wang XD. Alcohol and cancer. Alcohol Clin Exp Res. 2001;25(5 Suppl ISBRA):137S-43S. https://pubmed.ncbi.nlm.nih.gov/15082451/
673
Bailey LB. Folate, methyl-related nutrients, alcohol, and the MTHFR 677C®T polymorphism affect cancer risk: intake recommendations. J Nutr. 2003;133(11 Suppl 1):3748S-53S. https://pubmed.ncbi.nlm.nih.gov/14608109/
674
Griswold MG, Fullman N, Hawley C, et al. Alcohol use and burden for 195 countries and territories, 1990–2016: a systematic analysis for the Global Burden of Disease Study 2016. Lancet. 2018;392(10152):1015–35. https://pubmed.ncbi.nlm.nih.gov/30146330/
675
Bo Y, Zhu Y, Tao Y, et al. Association between folate and health outcomes: an umbrella review of meta-analyses. Front Public Health. 2020;8:550753. https://pubmed.ncbi.nlm.nih.gov/33384976/
676
Bo Y, Zhu Y, Tao Y, et al. Association between folate and health outcomes: an umbrella review of meta-analyses. Front Public Health. 2020;8:550753. https://pubmed.ncbi.nlm.nih.gov/33384976/
677
Crider KS, Bailey LB, Berry RJ. Folic acid food fortification – its history, effect, concerns, and future directions. Nutrients. 2011;3(3):370–84. https://pubmed.ncbi.nlm.nih.gov/22254102/
678
Bailey SW, Ayling JE. The extremely slow and variable activity of dihydrofolate reductase in human liver and its implications for high folic acid intake. Proc Natl Acad Sci U S A. 2009;106(36):15424–9. https://pubmed.ncbi.nlm.nih.gov/19706381/
679
Selhub J, Rosenberg IH. Excessive folic acid intake and relation to adverse health outcome. Biochimie. 2016;126:71–8. https://pubmed.ncbi.nlm.nih.gov/27131640/
680
Troen AM, Mitchell B, Sorensen B, et al. Unmetabolized folic acid in plasma is associated with reduced natural killer cell cytotoxicity among postmenopausal women. J Nutr. 2006;136(1):189–94. https://pubmed.ncbi.nlm.nih.gov/16365081/
681
Bo Y, Zhu Y, Tao Y, et al. Association between folate and health outcomes: an umbrella review of meta-analyses. Front Public Health. 2020;8:550753. https://pubmed.ncbi.nlm.nih.gov/33384976/
682
U.S. Preventive Services Task Force. Final recommendation statement: folic acid for the prevention of neural tube defects: preventive medication. U.S. Preventive Services Task Force. https://www.uspreventiveservicestaskforce.org/uspstf/recommendation/folic-acid-for-the-prevention-of-neural-tube-defects-preventive-medication. Published January 10, 2017. Accessed May 26, 2021.; https://www.uspreventiveservicestaskforce.org/uspstf/recommendation/folic-acid-for-the-prevention-of-neural-tube-defects-preventive-medication
683
Dudeja PK, Torania SA, Said HM. Evidence for the existence of a carrier-mediated folate uptake mechanism in human colonic luminal membranes. Am J Physiol. 1997;272(6Pt1):G1408–15. https://pubmed.ncbi.nlm.nih.gov/9227476/
684
Strozzi GP, Mogna L. Quantification of folic acid in human feces after administration of Bifidobacterium probiotic strains. J Clin Gastroenterol. 2008;42 Suppl 3 Pt 2:S179–84. https://pubmed.ncbi.nlm.nih.gov/18685499/
685
Rando TA, Chang HY. Aging, rejuvenation, and epigenetic reprogramming: resetting the aging clock. Cell. 2012;148(1–2):46–57. https://pubmed.ncbi.nlm.nih.gov/22265401/
686
Hellwig M, Henle T. Baking, ageing, diabetes: a short history of the Maillard reaction. Angew Chem Int Ed. 2014;53(39):10316–29. https://pubmed.ncbi.nlm.nih.gov/25044982/
687
Teodorowicz M, Hendriks WH, Wichers HJ, Savelkoul HFJ. Immunomodulation by processed animal feed: the role of Maillard reaction products and advanced glycation end-products (AGEs). Front Immunol. 2018;9:2088. https://pubmed.ncbi.nlm.nih.gov/30271411/
688
Sadowska-Bartosz I, Bartosz G. Effect of glycation inhibitors on aging and age-related diseases. Mech Ageing Dev. 2016;160:1–18. https://pubmed.ncbi.nlm.nih.gov/27671971/
689
Unnikrishnan R, Anjana RM, Mohan V. Drugs affecting HbA1c levels. Indian J Endocrinol Metab. 2012;16(4):528–31. https://pubmed.ncbi.nlm.nih.gov/22837911/
690
American Diabetes Association. Understanding A1C. American Diabetes Association website. https://www.diabetes.org/a1c. Accessed June 2, 2021.; https://www.diabetes.org/a1c
691
Sadowska-Bartosz I, Bartosz G. Effect of glycation inhibitors on aging and age-related diseases. Mech Ageing Dev. 2016;160:1–18. https://pubmed.ncbi.nlm.nih.gov/27671971/
692
Verzijl N, DeGroot J, Thorpe SR, et al. Effect of collagen turnover on the accumulation of advanced glycation end products. J Biol Chem. 2000;275(50):39027–31. https://pubmed.ncbi.nlm.nih.gov/10976109/
693
Fedintsev A, Moskalev A. Stochastic non-enzymatic modification of long-lived macromolecules – a missing hallmark of aging. Ageing Res Rev. 2020;62:101097. https://pubmed.ncbi.nlm.nih.gov/32540391/
694
Green AS. mTOR, glycotoxins and the parallel universe. Aging (Albany NY). 2018;10(12):3654–6. https://pubmed.ncbi.nlm.nih.gov/30540565/
695
Bettiga A, Fiorio F, Di Marco F, et al. The modern Western diet rich in advanced glycation end-products (AGES): an overview of its impact on obesity and early progression of renal pathology. Nutrients. 2019;11(8):1748. https://pubmed.ncbi.nlm.nih.gov/31366015/
696
Garay-Sevilla ME, Beeri MS, de la Maza MP, Rojas A, Salazar-Villanea S, Uribarri J. The potential role of dietary advanced glycation endproducts in the development of chronic non-infectious diseases: a narrative review. Nutr Res Rev. 2020;33(2):298–311.